Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Acute Care Syndromic Testing Market Through 2034?

In recent times, the acute care syndromic testing market has seen a significant rise in its size. The market, which is expected to increase from $4.08 billion in 2024 to $4.59 billion in 2025, will be growing at a compound annual growth rate (CAGR) of 12.3%. Factors contributing to the growth in the historic period include enhanced awareness of antimicrobial resistance, increased government funding for infectious diseases, greater investment in healthcare infrastructure, amplified focus on syndromic testing, expansion of telemedicine, and surge in infectious diseases.

Expect an upswing in the size of the acute care syndromic testing market in the coming years, rising to a substantial $7.39 billion in 2029 with a compound annual growth rate (CAGR) of 12.7%. The growth over this forecast period can be traced back to an increase in the occurrence of infectious diseases, a greater need for quick diagnostic solutions, broader healthcare services, the rising adoption of multiplex syndromic panels, and an increasing older population. The forecast period will also see trends like a lean toward point-of-care testing, the incorporation of cloud-based platforms, increased use of multiplex panels, the emergence of AI-powered tools, and the implementation of automation in syndromic testing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21078&type=smp

Which Factors and External Forces Are Driving Demand in the Acute Care Syndromic Testing Market?

The increasing occurrences of infectious illnesses is projected to drive the growth of the acute care syndromic testing market. These diseases, caused by harmful microscopic entities like bacteria, viruses, fungi, or parasites can be transmitted from person to person, animals, or even the environment. Aspects such as population growth, urbanization, global travel, antimicrobial resistance, and climate change contribute to these growing occurrences, thereby increasing the necessity for adequate prevention and treatment. The technique of acute care syndromic testing is employed in these infectious diseases to swiftly pinpoint pathogens and co-infections via multiplex molecular diagnostics, facilitating specific treatment decisions. For example, the Health Security Agency, a UK-based government unit, reported in February 2024 that the influenza positivity rate in the fourth week of 2024 surged to 16.6%, a rise from the previous week’s 14.0%. Consultations for influenza-like illnesses (ILI) also increased, hitting 9.8 per 100,000 people, as against 7.5 per 100,000 in the previous week. Likewise, there was an increase in influenza hospitalizations that week, jumping to 7.63 per 100,000 from 5.12 per 100,000 the prior week. Consequently, this escalating prevalence of infectious diseases is bolstering the acute care syndromic testing market.

Which Segments in the Acute Care Syndromic Testing Offer the Most Growth?

The acute care syndromic testingmarket covered in this report is segmented –

1) By Disease Type: Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types

2) By Sample Type: Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types

3) By Target: Bacteria, Viruses, Fungi, Parasites

4) By End User: Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users

Subsegments:

1) By Respiratory Diseases: Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases

2) By Gastrointestinal Diseases: Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases

3) By Genitourinary Diseases: Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases

4) By Tropical Diseases: Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases

5) By Other Disease Types: Meningitis, Sepsis, Other Emerging Infectious Diseases

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21078&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Acute Care Syndromic Testing Market?# Market?

North America was the largest region in the acute care syndromic testing market in 2024. The regions covered in the acute care syndromic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theAcute Care Syndromic Testing Market’s Growth?

Leading firms in the acute care syndromic testing market are placing an emphasis on technological advancements, with particular focus on multiplex real-time polymerase chain reaction (PCR) technology. This is done to boost diagnostic precision, expedite pathogen identification, streamline lab processes, cut down on response time and improve patient results through exact and timely treatment procedures. Multiplex real-time PCR technology is a cutting-edge diagnostic tool that concurrently detects and measures multiple pathogens or genetic targets in a single PCR reaction, thereby improving the efficacy and accuracy of disease diagnosis. In April 2023, for example, a biotechnology research company based in the Netherlands, QIAGEN N.V., unveiled its QIAstat-Dx syndromic testing solution in Japan, which includes a SARS-CoV-2 respiratory panel capable of detecting over 20 pathogens from one single sample using multiplex real-time PCR technology. This technology allows for faster results with less labor than traditional individual PCR assays. By the close of 2022, over 3,500 systems had been installed worldwide, aiding in the detection of respiratory, gastrointestinal and meningitis-related diseases. With the system available in over 100 countries, syndromic testing has become more accessible globally.

View the full report here:

https://www.thebusinessresearchcompany.com/report/acute-care-syndromic-testing-global-market-report

What Are the Key Elements That Define the Acute Care Syndromic Testing Market?

Acute care syndromic testing refers to a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. It is used in emergency and critical care settings to quickly diagnose infectious diseases. This enables faster treatment decisions, improved patient outcomes, and reduced hospital stays.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21078

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model